2023 ICD-10-CM Diagnosis Code D04

Carcinoma in situ of skin

    2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
  • D04 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.
  • The 2023 edition of ICD-10-CM D04 became effective on October 1, 2022.
  • This is the American ICD-10-CM version of D04 - other international versions of ICD-10 D04 may differ.
Type 1 Excludes
Type 1 Excludes Help
A type 1 excludes note is a pure excludes. It means "not coded here". A type 1 excludes note indicates that the code excluded should never be used at the same time as D04. A type 1 excludes note is for used for when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.
  • erythroplasia of Queyrat (penis) NOS (
    ICD-10-CM Diagnosis Code D07.4

    Carcinoma in situ of penis

      2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code Male Dx
    Applicable To
    • Erythroplasia of Queyrat NOS
    D07.4
    )
  • melanoma in situ (
    ICD-10-CM Diagnosis Code D03
    • D03 Melanoma in situ
      • D03.0 Melanoma in situ of lip
      • D03.1 Melanoma in situ of eyelid, including canthus...
        • D03.10 Melanoma in situ of unspecified eyelid, inclu...
        • D03.11 Melanoma in situ of right eyelid, including c...
          • D03.111 Melanoma in situ of right upper eyelid, inclu...
          • D03.112 Melanoma in situ of right lower eyelid, inclu...
        • D03.12 Melanoma in situ of left eyelid, including ca...
          • D03.121 Melanoma in situ of left upper eyelid, includ...
          • D03.122 Melanoma in situ of left lower eyelid, includ...
      • D03.2 Melanoma in situ of ear and external auricula...
        • D03.20 Melanoma in situ of unspecified ear and exter...
        • D03.21 Melanoma in situ of right ear and external au...
        • D03.22 Melanoma in situ of left ear and external aur...
      • D03.3 Melanoma in situ of other and unspecified par...
        • D03.30 Melanoma in situ of unspecified part of face
        • D03.39 Melanoma in situ of other parts of face
      • D03.4 Melanoma in situ of scalp and neck
      • D03.5 Melanoma in situ of trunk
        • D03.51 Melanoma in situ of anal skin
        • D03.52 Melanoma in situ of breast (skin) (soft tissu...
        • D03.59 Melanoma in situ of other part of trunk
      • D03.6 Melanoma in situ of upper limb, including sho...
        • D03.60 Melanoma in situ of unspecified upper limb, i...
        • D03.61 Melanoma in situ of right upper limb, includi...
        • D03.62 Melanoma in situ of left upper limb, includin...
      • D03.7 Melanoma in situ of lower limb, including hip...
        • D03.70 Melanoma in situ of unspecified lower limb, i...
        • D03.71 Melanoma in situ of right lower limb, includi...
        • D03.72 Melanoma in situ of left lower limb, includin...
      • D03.8 Melanoma in situ of other sites
      • D03.9 Melanoma in situ, unspecified
    D03.-
    )
The following code(s) above D04 contain annotation back-references
Annotation Back-References
In this context, annotation back-references refer to codes that contain:
  • Applicable To annotations, or
  • Code Also annotations, or
  • Code First annotations, or
  • Excludes1 annotations, or
  • Excludes2 annotations, or
  • Includes annotations, or
  • Note annotations, or
  • Use Additional annotations
that may be applicable to D04:
  • C00-D49
    2023 ICD-10-CM Range C00-D49

    Neoplasms

    Note
    • Functional activity
    • All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
    • Morphology [Histology]
    • Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
    • Primary malignant neoplasms overlapping site boundaries
    • A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
    • Malignant neoplasm of ectopic tissue
    • Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
    Neoplasms
  • D00-D09
    2023 ICD-10-CM Range D00-D09

    In situ neoplasms

    Includes
    • Bowen's disease
    • erythroplasia
    • grade III intraepithelial neoplasia
    • Queyrat's erythroplasia
    In situ neoplasms
Clinical Information
  • Abnormal cells are found in the lower part of the epidermis (the outer layer of the skin). These abnormal cells may become cancer and spread into nearby normal tissue.
  • Stage 0 includes: tis, n0, m0. Tis: carcinoma in situ. N0: no regional lymph node metastasis. M0: no clinical or radiographic evidence of distant metastasis. (ajcc 6th and 7th eds.)
  • Stage 0: tis: carcinoma in situ; n0: no regional lymph node metastasis; m0: no distant metastasis. (based on ajcc cancer staging).
Code History
  • 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
  • 2017 (effective 10/1/2016): No change
  • 2018 (effective 10/1/2017): No change
  • 2019 (effective 10/1/2018): No change
  • 2020 (effective 10/1/2019): No change
  • 2021 (effective 10/1/2020): No change
  • 2022 (effective 10/1/2021): No change
  • 2023 (effective 10/1/2022): No change
Code annotations containing back-references to D04:
  • Applicable To: Z86.007
    ICD-10-CM Diagnosis Code Z86.007

    Personal history of in-situ neoplasm of skin

      2020 - New Code 2021 2022 2023 Billable/Specific Code POA Exempt
    Applicable To
    • Conditions classifiable to D04
    • Personal history of carcinoma in situ of skin
ICD-10-CM Codes Adjacent To D04
D03.6 Melanoma in situ of upper limb, including shoulder
D03.60 Melanoma in situ of unspecified upper limb, including shoulder
D03.61 Melanoma in situ of right upper limb, including shoulder
D03.62 Melanoma in situ of left upper limb, including shoulder
D03.7 Melanoma in situ of lower limb, including hip
D03.70 Melanoma in situ of unspecified lower limb, including hip
D03.71 Melanoma in situ of right lower limb, including hip
D03.72 Melanoma in situ of left lower limb, including hip
D03.8 Melanoma in situ of other sites
D03.9 Melanoma in situ, unspecified
D04 Carcinoma in situ of skin
D04.0 Carcinoma in situ of skin of lip
D04.1 Carcinoma in situ of skin of eyelid, including canthus
D04.10 Carcinoma in situ of skin of unspecified eyelid, including canthus
D04.11 Carcinoma in situ of skin of right eyelid, including canthus
D04.111 Carcinoma in situ of skin of right upper eyelid, including canthus
D04.112 Carcinoma in situ of skin of right lower eyelid, including canthus
D04.12 Carcinoma in situ of skin of left eyelid, including canthus
D04.121 Carcinoma in situ of skin of left upper eyelid, including canthus
D04.122 Carcinoma in situ of skin of left lower eyelid, including canthus
D04.2 Carcinoma in situ of skin of ear and external auricular canal

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.